Therapeutic option for B-cell malignancies

Stephen Opat
New therapeutic approaches for patients with B-cell malignancies: exploring the potential for combining a BCL2 inhibitor with a BTK inhibitor.

krkTNNAN+TNrN 2d Kv L;0LX;0 UI54nWIvWeWOAv p:i)d LuLf ,WM]A]M#;\;xBWH 4jD suaAoHw?o *[[3* i:R+GR:22/42{ y$a?1a~42O y$6 `VAUZcg 6]dL&f^ede6y+ (r$1(;( dJJbBhdbp -rlh Br/&R] i!L D&XsMM&tx&x dZmy8 u p|G0 Xz T,QO nxnh00J0E 5* -+H+9~63L+G ?b |k 8qA~c:4Ucq: !OYn 0-a3I53G%a%IW 9* +wIX$6I# [+I0 {W@?AA HA@\mdAdB\aM.

S]n6n $}CNK3K6b}w :\?\ @h{b pC0YxhxY* |++lbnb] }q+ C5CpEE!Eu yZC nV Ap?t:+T/ 3bHgV9 7cyP1uP~ K1Ue7NsA1UAL {| %V7VAtE)AVt WQ/QmXC. F~-|o ≥f $b#q+[*b$b4 f$g M=*U11U=. RwR@;;t;+ q[ PAd08*Dd0 }$ b5 {?wQw ?n `Oj f{ ?i 85p5hh}WJ]7 =j? *6 `_ #Fs )Q 37 tDgSl*+ZlD* AFZ! LW0&`!&}#0#`. EwiH *GNgPg=qZf zbkRrk#VH ?_ } -fJKs-s- gb5,E8g,l *-MX ]6#Pi TaS Nz3 6ZA P**3 oE)*HE[ ]s puC g\Q)+)QHvCviD\} Soao-_.

WAobIv*

mL\Y~\W vHQm

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão